Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group

Lancet. 1997 Jun 28;349(9069):1884. doi: 10.1016/s0140-6736(05)63874-3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acquired Immunodeficiency Syndrome / genetics*
  • Acquired Immunodeficiency Syndrome / immunology
  • Acquired Immunodeficiency Syndrome / mortality
  • Alleles
  • CD4 Lymphocyte Count
  • Follow-Up Studies
  • Gene Deletion*
  • HIV Seropositivity / genetics*
  • HIV Seropositivity / immunology
  • HIV Seropositivity / mortality
  • HIV-1 / genetics*
  • Heterozygote
  • Homozygote
  • Humans
  • Male
  • Receptors, CCR5
  • Receptors, Cytokine / genetics*
  • Receptors, HIV / genetics*
  • Survival Rate

Substances

  • Receptors, CCR5
  • Receptors, Cytokine
  • Receptors, HIV